Search

Search Constraints

You searched for: Author/Creator Moran, Susan

Search Results

2. Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study. (October 2021)

3. Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell‐free DNA results. Issue 11 (24th March 2020)

4. Interdisciplinary Teamwork and the Power of a Quality Improvement Collaborative in Tertiary Neonatal Intensive Care Units. Issue 2 (April 2015)

5. Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2017)

6. Orchestrated Testing: An Innovative Approach to a Multicenter Improvement Collaborative. (January 2017)